IntegenX
Pleasanton · Founded 2006
About IntegenX
IntegenX, Inc. designs, manufactures, and markets automation systems that enable reliable microsample preparation and analysis for the life sciences. It offers Apollo 100, a platform that allows the processing of DNA sequencing reactions; Apollo 200, an integrated sample preparation system for human DNA identification; microfluidics for DNA sequencing, molecular diagnostics, and human identification applications; and Apollo 324 system, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The company was formerly known as Microchip Biotechnologies, Inc. and changed its name to IntegenX, Inc. in March 2010. The company was incorporated in 2003 and is based in Pleasanton, California.
Company Facts
- Founded: 2006
- Legal name: IntegenX Inc.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $88.2M
- Funding stage: M&A
- Last round: Debt Financing (Sep 2014)
- Website: integenx.com
- Phone: 9255747373
Social Profiles
Canonical: https://fsome.com/organization/integenx-8404608 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.